查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1325094

連續性腎臟替代治療 (CRRT) 的全球市場

Continuous Renal Replacement Therapy (CRRT)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 216 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球持續性腎臟替代治療 (CRRT) 市場將達到 21 億美元

在COVID-19之後的商業環境發生變化的情況下，連續性腎臟替代療法（CRRT）的全球市場規模預計到2022年為13億美元，預計到2030年將達到21億美元，年複合成長率預計為5.7 % 到 2030 年。本報告分析的細分市場之一，即透析液和置換液，預計年複合成長率5.2%，到分析期結束時將達到 13 億美元。鑑於大流行後的持續復甦，拋棄式用品和系統領域的成長已將未來八年的年複合成長率修正為 6.8%。

美國市場預計達3.51億美元，中國預計年複合成長率為8.4%

到 2022 年，美國連續腎臟替代治療 (CRRT) 市場預計將達到 3.51 億美元。中國作為世界第二大經濟體，預計到2030年市場規模將達到3.166億美元，2022年至2030年的分析期間年複合成長率為8.4%。其他值得注意的地域市場包括日本和加拿大，預計 2022 年至 2030 年將分別成長 3.4% 和 4.7%。在歐洲，德國的年複合成長率預計約為 3.9%。

受訪企業示例

  • Toray Industries, Inc.
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Baxter International, Inc.
  • B. Braun Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Nikkiso Co., Ltd.
  • Fresenius Medical Care AG & Co. KgaA
  • Asahi Kasei Medical Co., Ltd.
  • Medica SpA
  • NxStage Medical, Inc.
  • Nipro India Corporation Pvt., Ltd.
  • Xenios AG
  • Infomed SA

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP11315

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $2.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Continuous Renal Replacement Therapy (CRRT) estimated at US$1.3 Billion in the year 2022, is projected to reach a revised size of US$2.1 Billion by 2030, growing at aCAGR of 5.7% over the period 2022-2030. Dialysates & Replacement Fluids, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$1.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Disposables & Systems segment is readjusted to a revised 6.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $351 Million, While China is Forecast to Grow at 8.4% CAGR

The Continuous Renal Replacement Therapy (CRRT) market in the U.S. is estimated at US$351 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$316.6 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 4.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 18 Featured) -

  • Toray Industries, Inc.
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Baxter International, Inc.
  • B. Braun Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Nikkiso Co., Ltd.
  • Fresenius Medical Care AG & Co. KgaA
  • Asahi Kasei Medical Co., Ltd.
  • Medica SpA
  • NxStage Medical, Inc.
  • Nipro India Corporation Pvt., Ltd.
  • Xenios AG
  • Infomed SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Continuous Renal Replacement Therapy Market Set for a Steady Growth
    • Dialysates & Replacement Fluids Dominate the Market, Disposables to Register the Fastest Growth
    • Continuous Venovenous Hemofiltration (CVVH) Leads the Market, CVVHDF to Exhibit the Fastest Growth
    • Europe and US Hold the Largest Share, China to Witness Fastest Growth
    • Continuous Renal Replacement Therapy (CRRT) - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Future Endeavors in CRRT
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increase in Incidence of Acute Kidney Injury to Drive Market Growth
    • Rise in Aging Population, Growing Number of ICU Patients Spurs the Need for CRRT
    • Global Population Statistics for the 60+ Age Group by Region (in Thousands): 2017
    • Rising Incidence of Diabetes: A Key Risk Factor for Acute Kidney Failure
    • TABLE 11: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
    • Increasing Incidence of Cardiovascular Disease Drive Market Growth
    • Prevalence of Heart Failure in Select Countries
    • Advancements in CRRT Machines: Designed for Reliable and Safe Treatment
    • Technological Advancements to Bolster Market Growth
    • Development of CRRT System for Pediatric Patients
    • Miniaturization and Wearable Technology Forays into Acute Renal Replacement Domain
    • Reimbursement Scenario
    • Development of New Hemofilters to Propel Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dialysates & Replacement Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Dialysates & Replacement Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Dialysates & Replacement Fluids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Disposables & Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Disposables & Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Disposables & Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemofiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Continuous Venovenous Hemofiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Continuous Venovenous Hemofiltration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Continuous Venovenous Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Continuous Venovenous Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemodiafiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Continuous Venovenous Hemodiafiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Continuous Venovenous Hemodiafiltration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Slow Continuous Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Slow Continuous Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Slow Continuous Filtration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Continuous Renal Replacement Therapy (CRRT) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • JAPAN
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • CHINA
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: China 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: China 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • EUROPE
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • FRANCE
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: France 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: France 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • GERMANY
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2023 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2023 & 2030

IV. COMPETITION